Researcher profile

William Hogan

William Hogan contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
4topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

An Overview of Distant Supervision for Relation Extraction with a Focus on Denoising and Pre-training Methods

Relation Extraction (RE) is a foundational task of natural language processing. RE seeks to transform raw, unstructured text into structured knowledge by identifying relational information between entity pairs found in text. RE has numerous uses, such as knowledge graph completion, text summarization, question-answering, and search querying. The history of RE methods can be roughly organized into four phases: pattern-based RE, statistical-based RE, neural-based RE, and large language model-based RE. This survey begins with an overview of a few exemplary works in the earlier phases of RE, highlighting limitations and shortcomings to contextualize progress. Next, we review popular benchmarks and critically examine metrics used to assess RE performance. We then discuss distant supervision, a paradigm that has shaped the development of modern RE methods. Lastly, we review recent RE works focusing on denoising and pre-training methods.

preprint2021arXiv

Applications of artificial intelligence in drug development using real-world data

The US Food and Drug Administration (FDA) has been actively promoting the use of real-world data (RWD) in drug development. RWD can generate important real-world evidence reflecting the real-world clinical environment where the treatments are used. Meanwhile, artificial intelligence (AI), especially machine- and deep-learning (ML/DL) methods, have been increasingly used across many stages of the drug development process. Advancements in AI have also provided new strategies to analyze large, multidimensional RWD. Thus, we conducted a rapid review of articles from the past 20 years, to provide an overview of the drug development studies that use both AI and RWD. We found that the most popular applications were adverse event detection, trial recruitment, and drug repurposing. Here, we also discuss current research gaps and future opportunities.